Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Potassium citrate malate is primarily justified by scientific evidence in the support or treatment of uric acid retention, particularly in the management of conditions like gout and uric acid nephrolithiasis (kidney stones). Potassium citrate (and its variants, including citrate malate) acts as an alkalinizing agent. By increasing urinary pH, it enhances the solubility of uric acid, reducing its crystallization and promoting its excretion. Multiple clinical studies have demonstrated that oral potassium citrate therapy can effectively raise urinary pH and decrease the risk of uric acid stone formation. For example, a randomized controlled trial published in the Journal of Urology (2005) found that potassium citrate significantly decreased uric acid stone recurrence in patients with a history of uric acid nephrolithiasis.

While most studies are on potassium citrate, potassium citrate malate is considered to have a similar mechanism and efficacy due to its provision of both potassium and citrate ions. The malate component may further support urine alkalinization, though direct comparative studies are limited. Overall, the scientific rationale is robust for the use of citrate salts in uric acid retention conditions, with potassium citrate malate being a logical extension. However, evidence specifically for the malate form is less extensive than for potassium citrate alone, hence a rating of 4 out of 5.

More about Potassium citrate malate
More about Uric Acid Retention

Other ingredients used for Uric Acid Retention

Other health conditions supported by Potassium citrate malate

Products containing Potassium citrate malate